Fenugreek Oil  

The plant has been used traditionally in Indian Ayurvedic medicines as well as in traditional Tibetan and Chinese medication for several centuries. Modern research has also demonstrated that fenugreek seed and leaves are useful in the treatment of a number of diseases including successfully reducing blood sugar and blood cholesterol levels in both animals and humans. The plant has recently attracted great interest in the pharmaceutical, nutraceutical and functional food industries due to its rich medicinal properties.

Fenugreek Essential Oil in Pharma

Fenugreek has a beneficial effect on cleansing the blood, and as a diaphoretic, it is able to bring on sweat and to help detox the body. The galactomannan-rich soluble fiber fraction of fenugreek seeds may be responsible for the antidiabetic activity. The plant seeds are used in Asia, Africa, and Mediterranean countries as one of the ingredients in daily diets and in some domains such as medicine, nutrition, beverages, fragrances, cosmetics, or industrial purposes. The pharmacological effects of fenugreek are antimicrobial, anticholesterolemic, carminative, febrifuge, laxative, restorative, uterine tonic, expectoral, galactogogue, anticarcinogenic, antiinflammatory, antiviral, antioxidant, hypotensive, etc.

Essence of Fenugreek Essential Oil

The fresh green leaves of T. foenum-graecum consumed as vegetables, dried seeds are used as spice in food preparation, and both leaves and seeds are used in flavoring foods in many countries including India; the seed constitutes an essential part of Bengali five-spice mixture panch foron that makes the food tasty and provide attractive flavor during preparation. The T. foenum-graecum seed can be cooked or sprouted and can even be eaten raw; the whole seeds are taken as an antacid and against dysentery and stomach disturbances.

COMMON USAGE

·        Good for breastfeeding mothers

·        Reduces menstrual discomfort

·        Minimizes symptoms of menopause

·        Lowers cholesterol

·        Reduces cardiovascular risks

·        Controls diabetes

·        Relieves sore throat

·        Relieves constipation

·        Treats kidney problems

·        Prevents colon cancer

·        Suppresses appetite 

Ingredients:

TOXICOLOGICAL INFORMATION

Safety Summary

·        Hazards: drug interaction.

·        Cautions (oral): diabetes medication

Organ-specific effects

·        Adverse skin reactions: No information found for fenugreek oil. Undiluted fenugreek absolute was moderately irritating to rabbits, but was not irritating to mice or pigs; tested at 2% on 25 volunteers it was neither irritating nor sensitizing. It is non-phototoxic.

·        Cardiovascular effect: Dietary fenugreek oil fed to male alloxan-diabetic rats at 5%, significantly inhibited a-amylase and maltase activity in the pancreas and plasma, and improved glucose tolerance.

Systemic effects

·        Acute toxicity: Fenugreek absolute acute oral LD50 in rats >5 g/kg; acute dermal LD50 in rabbits >2 g/kg. No information was found for fenugreek oil.

·        Carcinogenic/ anticarcinogenic potential: No information! found for fenugreek oil or absolute, but neither contains any known carcinogens. a-Cadinol is active against the human colon cancer cell line HT-29.

·        Drug interactions: Antidiabetic medication, because of cardiovascular effects, above.

·        Serious eye damage / irritation: Not classified.

·        Germ Cell Mutagenicity: Not classified.

·        Carcinogenicity: Not classified.

·        Reproductive toxicity: Not classified.

·        STOT-single exposure: Not classified.

·        STOT-repeated exposure: Not classified.

·        Aspiration hazard: May be fatal if swallowed and enters airways.

·        Photo-toxicity: No additional data available.

ECOLOGICAL INFORMATION

·        Toxicity: Not Determined

·        Persistence & degradability Biodegradability: no degradability data is available; the substance is considered as not degrading quickly.

·        Bioaccumulation Potential: No additional data available.

·        Mobility in soil: No additional data available.

·        Results of PBT and vPvB Assessment: No additional data available.